SonoScape Medical Corp.

Shenzhen Stock Exchange 300633.SZ

SonoScape Medical Corp. Free Cash Flow for the year ending December 31, 2023: USD 44.01 M

SonoScape Medical Corp. Free Cash Flow is USD 44.01 M for the year ending December 31, 2023, a 7.35% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

SonoScape Medical Corp. Free Cash Flow for the year ending December 31, 2022 was USD 41.00 M, a 72.82% change year over year.
SonoScape Medical Corp. Free Cash Flow for the year ending December 31, 2021 was USD 23.72 M, a 33.68% change year over year.
SonoScape Medical Corp. Free Cash Flow for the year ending December 31, 2020 was USD 17.75 M, a 291.10% change year over year.
SonoScape Medical Corp. Free Cash Flow for the year ending December 31, 2019 was USD 4.54 M, a -79.57% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Shenzhen Stock Exchange: 300633.SZ

SonoScape Medical Corp.

CEO	Mr. Kunxiang Wu
IPO Date	April 7, 2017
Location	China
Headquarters	Shenzhen Software Park, 12
Employees	2,697
Sector	Healthcare
Industries Medical Instruments 3D Printing Biotechnology Defense & Military Hardware & Electronics Plastics Robotics

Description

SonoScape Medical Corp. develops and manufactures medical equipment in China and internationally. The company offers ultrasound diagnostic systems, such as trolley color Doppler, portable color Doppler, B/W ultrasound, and veterinary ultrasound equipment; and endoscopy equipment, such as image processors, light sources, and gastroenterology products. It also provides technical and spare parts support, training, upgradation, and field services. SonoScape Medical Corp. was founded in 2002 and is based in Shenzhen, China.

Key trends

Past 5 years